Starpharma and Lilly agree drug delivery collaboration

Starpharma Holdings of Melbourne, Australia, has signed a new agreement with Eli Lilly, which will use Starpharma's dendrimer drug delivery technology in its human pharmaceutical product line.

Starpharma Holdings of Melbourne, Australia, has signed a new agreement with Eli Lilly, which will use Starpharma's dendrimer drug delivery technology in its human pharmaceutical product line.

As part of the agreement Indianapolis-based pharmaceutical firm Lilly will fund a collaborative research and development programme with the aim of creating improved drugs incorporating Starpharma's proprietary delivery technology, which will then be commercialised by Lilly.

Starpharma already has an agreement with Lilly's animal health division Elanco, signed last May, for the development of animal health products with enhanced properties.




Companies